BlackBerry Ltd. (NASDAQ:BBRY) is selling a new, inexpensive smartphone as it fights its decline in the mobile market now dominated by Android devices and the iPhone. BlackBerry Ltd (NASDAQ:BBRY) net profit margin is -6.73% and weekly performance is -0.48%. On last trading day company shares ended up $7.26. Analysts mean target price for the company is $10.90. BlackBerry Ltd (NASDAQ:BBRY) distance from 50-day simple moving average (SMA50) is -11.29%.
Fate Therapeutics (NASDAQ:FATE) released its earnings data on Tuesday. The company reported ($0.34) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.33) by $0.01, American Banking and Market News reports. Fate Therapeutics Inc. (NASDAQ:FATE) shares fell -0.60% in last trading session and ended the day on $6.65. FATE return on assets is -251.00%.Fate Therapeutics Inc. (NASDAQ:FATE) quarterly performance is 10.65%.
On May 8, 2014, PharmAthene, Inc. (NYSEMKT:PIP) issued a press release announcing its financial and operating results for the quarter ended March 31, 2014. PharmAthene, Inc. (NYSEMKT:PIP) shares moved down -2.03% in last trading session and was closed at $1.45, while trading in range of $1.45 – $1.55. PharmAthene, Inc. (NYSEMKT:PIP) year to date (YTD) performance is -22.04%.
AOL, Inc. (NYSE:AOL) announced that John Baylon is joining the company as Head of UK and European Trading. Baylon will focus on driving the relationships with major and independent holding companies and agency trading groups, to further strengthen AOL’s position in the market. On last trading day company shares ended up $36.81.
Mera Pharmaceuticals Inc. (OTCMKTS:MRPI) shares moved down -38.46% in last trading session and was closed at $0.0008.